Drug Interactions between Auryxia and Velphoro
This report displays the potential drug interactions for the following 2 drugs:
- Auryxia (ferric citrate)
- Velphoro (sucroferric oxyhydroxide)
Interactions between your drugs
No interactions were found between Auryxia and Velphoro. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Auryxia
A total of 52 drugs are known to interact with Auryxia.
- Auryxia is in the drug class phosphate binders.
- Auryxia is used to treat the following conditions:
Velphoro
A total of 26 drugs are known to interact with Velphoro.
- Velphoro is in the drug class phosphate binders.
- Velphoro is used to treat Hyperphosphatemia of Renal Failure.
Drug and food interactions
ferric citrate food
Applies to: Auryxia (ferric citrate)
Food may reduce the absorption and blood levels of ferric citrate. In addition, some oral medications can also interfere with ferric citrate absorption into the bloodstream, which may make the medication less effective in treating your condition. Likewise, ferric citrate may interfere with the absorption of other orally administered medications. You should take ferric citrate on an empty stomach at least one hour before or two hours after a meal. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring to safely use both medications. Talk to your doctor or pharmacist if you have questions about how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
Phosphate binders
Therapeutic duplication
The recommended maximum number of medicines in the 'phosphate binders' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'phosphate binders' category:
- Auryxia (ferric citrate)
- Velphoro (sucroferric oxyhydroxide)
Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.